Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial. Metzger Filho O, Cardoso F, Poncet C, Desmedt C, et al. Eur J Cancer 2025;217:115222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Metzger Filho O, Cardoso F, Poncet C, Desmedt C, et al. Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial. Eur J Cancer 2025;217:115222.
PMID: 39864363